LENZ Therapeutics, Inc. - LENZ
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Sep 08, 2026 | SCHEDULE 13G/A | FMR LLC | 5.7% | 1,783,202 | View |
| Sep 08, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 5.7% | 1,783,202 | View |
| Jun 26, 2026 | SCHEDULE 13G | Millennium Management LLC | 5.1% | 1,603,512 | View |
| Jun 26, 2026 | SCHEDULE 13G | Millennium Group Management LLC | 5.1% | 1,603,512 | View |
| Jun 26, 2026 | SCHEDULE 13G | Israel A. Englander | 5.1% | 1,603,512 | View |
| Apr 27, 2026 | SCHEDULE 13G | BlackRock, Inc. | 5.8% | 1,804,099 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.